Calif. Pharmacies Sue Pfizer, Ranbaxy Over Lipitor Deal

Law360, New York (November 8, 2011, 10:01 PM EST) -- Eleven California pharmacies sued Pfizer Inc., generics maker Ranbaxy Pharmaceuticals Inc. and others on Monday, saying an anti-competitive agreement between the drug companies forced them to pay higher prices for the cholesterol treatment Lipitor for longer than necessary.

The agreement between Pfizer and Ranbaxy — which was the first company to challenge Pfizer's patents on Lipitor when it filed its abbreviated new drug application nine years ago — has delayed the entry of generic versions of Lipitor into the U.S. market for up to 20 months...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.